Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Berthold

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Cancer Research : MCR|March 15, 2023
Interdependence of SS18-SSX-driven YAP1 and β-Catenin Activation in Synovial SarcomaIlka Isfort, Ruth Berthold, Lorena Heinst, et al.
Cells|December 24, 2025
SS18::SSX and BRD9 Modulate Synovial Sarcoma DifferentiationAnna Kuntze, Victor Banerjee, Marcel Trautmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 2, 2021
Recurrent CTNNB1 mutations in craniofacial osteomasDaniel Baumhoer, Ruth Berthold, Ilka Isfort, et al.
Oncogenesis|April 23, 2022
Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcomaRuth Berthold, Ilka Isfort, Cihan Erkut, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2024
Exploiting WEE1 Kinase Activity as FUS::DDIT3-Dependent Therapeutic Vulnerability in Myxoid LiposarcomaLorena Heinst, Kwang Seok Lee, Ruth Berthold, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 13, 2022
SS18-SSX drives CREB activation in synovial sarcomaMagdalene Cyra, Miriam Schulte, Ruth Berthold, et al.
Scientific Reports|December 25, 2019
Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and BoneIlka Isfort, Sandra Elges, Magdalene Cyra, et al.
EMBO Molecular Medicine|March 23, 2019
Requirement for YAP1 signaling in myxoid liposarcomaMarcel Trautmann, Ya-Yun Cheng, Patrizia Jensen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 13, 2026
VGLL3-rearranged Spindle Cell Rhabdomyoblastic Tumor: A Clinicopathologic and Molecular Genetic Study of 18 Cases with Consistently Indolent BehaviorEsther Baranov, Baptiste Ameline, Ruth Berthold, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Cancer Research : MCR|March 15, 2023
Interdependence of SS18-SSX-driven YAP1 and β-Catenin Activation in Synovial SarcomaIlka Isfort, Ruth Berthold, Lorena Heinst, et al.
Cells|December 24, 2025
SS18::SSX and BRD9 Modulate Synovial Sarcoma DifferentiationAnna Kuntze, Victor Banerjee, Marcel Trautmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 2, 2021
Recurrent CTNNB1 mutations in craniofacial osteomasDaniel Baumhoer, Ruth Berthold, Ilka Isfort, et al.
Oncogenesis|April 23, 2022
Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcomaRuth Berthold, Ilka Isfort, Cihan Erkut, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2024
Exploiting WEE1 Kinase Activity as FUS::DDIT3-Dependent Therapeutic Vulnerability in Myxoid LiposarcomaLorena Heinst, Kwang Seok Lee, Ruth Berthold, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 13, 2022
SS18-SSX drives CREB activation in synovial sarcomaMagdalene Cyra, Miriam Schulte, Ruth Berthold, et al.
Scientific Reports|December 25, 2019
Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and BoneIlka Isfort, Sandra Elges, Magdalene Cyra, et al.
EMBO Molecular Medicine|March 23, 2019
Requirement for YAP1 signaling in myxoid liposarcomaMarcel Trautmann, Ya-Yun Cheng, Patrizia Jensen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 13, 2026
VGLL3-rearranged Spindle Cell Rhabdomyoblastic Tumor: A Clinicopathologic and Molecular Genetic Study of 18 Cases with Consistently Indolent BehaviorEsther Baranov, Baptiste Ameline, Ruth Berthold, et al.
Pageof 1